EssilorLuxottica stock holds buyback line as Q2 2026 revenue accelerates

EssilorLuxottica stock is navigating 2026 with a mix of buyback support and earnings momentum, even as the American depositary receipt trades more than 40 percent below its opening level for the year, with the company identified under ISIN FR0000121667 and a key price snapshot as of August 31, 2026.

Per recent quote data tied to the EssilorLuxottica ESLOY depositary receipt on the US over-the-counter market as of August 31, 2026, the shares closed at $92.79, translating into a market capitalization of $86.15 billion and a year-to-date decline of 41.4 percent from a starting 2026 level of $158.42. This quote overview highlights that the stock has fallen sharply since January yet continues to trade with solid liquidity.

At the same time, EssilorLuxottica has underpinned its capital-market story with a new share buyback program and mid-single- to high-single-digit revenue growth in the latest quarter and half-year, setting a different tone from the price performance and giving long-term investors fresh numbers to weigh.

Buyback and own-share transactions signal capital-return focus

EssilorLuxottica has recently launched a share buyback framework that grants a mandate to an investment services provider to repurchase up to 5 million shares, reinforcing the message that management sees value in retiring equity at current levels and supporting earnings per share over time. A business report notes that the company characterizes the initiative as a sign of confidence in its ability to create value on a long horizon.

The buyback activity is visible in regulatory disclosures of transactions in own shares filed around August 31, 2026, where EssilorLuxottica reports the total daily volume of repurchases, the weighted-average purchase price in euros and the trading venue where each block of stock was bought. One such filing sets out a table that includes identity codes for the issuer and instrument, as well as the daily number of shares and weighted-average euro purchase price, underscoring that the buyback drive is active rather than theoretical.

A separate company-news feed on the Euronext platform also lists two EssilorLuxottica items dated August 31, 2026, both labeled as disclosures of transactions in own shares, which confirms that the group has been consistently executing the repurchase mandate in late August and into the turn of the month. This Euronext listing reinforces the quantitative picture from the transaction tables.

Q2 and H1 2026 results show accelerating revenue growth

The most recent financial disclosure for EssilorLuxottica covers the first half of 2026, ending June 30, 2026, and points to an acceleration in revenue growth between the first and second quarters that stands in contrast to the share price retracement seen since January. A detailed half-year overview indicates that EssilorLuxottica generated revenue of EUR 14,818 million in the first six months of 2026, a 5.7 percent increase compared with the same period a year earlier, and a 9.7 percent rise at constant exchange rates.

Within that half-year, the second quarter of 2026 contributed EUR 7,692 million of revenue, representing year-over-year growth of 7.2 percent and an 8.7 percent increase at constant exchange rates, suggesting that momentum in the core eyewear and optical business strengthened as mid-2026 approached. The jump from 5.7 percent half-year reported growth to 7.2 percent in the second quarter, with an even higher constant-currency rise, offers investors a concrete sign that EssilorLuxottica is not just relying on buybacks but also on organic volume and pricing dynamics to support its equity story.

From a margin perspective, the same results set points to an increase in adjusted operating profit of 15 percent in the first half of 2026, highlighting that profitability is growing faster than revenue and that cost discipline and mix improvements are helping the company expand earnings faster than top line. In practical terms, a 15 percent adjusted operating profit growth rate versus 5.7 percent reported revenue growth translates into operational leverage that can underpin earnings-per-share trajectories once buyback effects are factored in.

For investors tracking consensus, these H1 2026 numbers mark the latest core fundamental snapshot within the freshness window for the period ending June 30, 2026 and will typically feed into sell-side models as the base case until the next quarterly update. That means the 7.2 percent second-quarter revenue increase at reported rates and 8.7 percent constant-currency growth now form the primary quantitative reference points for assessing EssilorLuxottica’s short-term growth profile, while the 15 percent adjusted operating profit gain frames the profitability outlook.

Listing structure and trading venues for EssilorLuxottica stock

EssilorLuxottica shares are primarily listed on Euronext Paris under the ticker EL, representing the group’s French incorporation, while US investors typically access the company via the ESLOY American depositary receipt on the over-the-counter market. A recent equity analysis notes that a highlighted late-August 2026 session on Euronext Paris saw the EL line close at EUR 161.35, marking an intraday increase of EUR 10.75 or 2.40 percent and positioning the shares above the weighted-average repurchase price disclosed in buyback documentation.

On the US OTC market, the ESLOY depositary receipt recorded a close at $93.72 on August 28, 2026 at 3:59 p.m. ET with a daily gain of $2.15, equivalent to a 2.35 percent increase, while still leaving the year-to-date performance down 40.8 percent versus the January 1, 2026 level of $158.42. The comparison between the $93.72 late-August quote and the $92.79 close as of August 31, 2026 underscores that the stock has moved within a relatively narrow band over those sessions, with the broader story still dominated by the pronounced decline versus the start of 2026 rather than by short-term fluctuations.

For euro-based investors, recent Euronext data show individual trades in the EL line executed at EUR 160.35 on August 31, 2026, illustrating the granular depth of the order book and reinforcing the picture of a share price that, while volatile over the year, is actively supported by buyback transactions and steady institutional interest. A French market-quote feed lists time-stamped trades at EUR 160.350 in the closing minutes of the session, which aligns with the broader late-August price area.

Competitive context and sector peers

In the broader optical and eyewear sector, EssilorLuxottica’s 5.7 percent half-year revenue increase and 7.2 percent second-quarter growth put it in a solid position relative to peers that are reporting lower single-digit sales expansions. For example, another eyewear and optical-focused group reported consolidated sales of EUR 1.25 billion for the first half of 2026, representing a 2 percent year-over-year increase compared with EUR 1.23 billion in the prior-year period, underscoring that EssilorLuxottica’s growth profile is more robust than at least one major European competitor.

A 5.7 percent first-half 2026 revenue rise versus a 2 percent peer increase means EssilorLuxottica’s top line expanded more than twice as fast, a concrete difference that may matter for investors looking for growth exposure in a mature consumer-health segment. At the same time, the 15 percent adjusted operating profit increase points to superior earnings momentum versus peers that have reported high-single-digit profit gains, suggesting that EssilorLuxottica is leveraging scale, brand strength and integration of its eyewear and lens operations to squeeze more margin out of comparable sales growth.

Sector-wide, discretionary consumer spending and health-care budgets continue to shape demand for prescription eyewear, sunglasses and optical services, but EssilorLuxottica’s ability to deliver mid-single-digit reported revenue growth and high-single-digit constant-currency increases in the latest quarter and half-year indicates resilience against macro headwinds. The combination of structural drivers, such as aging populations and increasing screen use, and the premium positioning of flagship brands gives the company a platform that can absorb short-term shocks while maintaining a positive growth trajectory.

Representative product: Ray-Ban eyewear in the EssilorLuxottica portfolio

One of the best-known examples of EssilorLuxottica’s product and brand power is Ray-Ban, a leading eyewear label that spans prescription frames and sunglasses and is integrated into the group’s distribution channels and lens offerings. Ray-Ban’s catalog includes iconic styles such as Aviator and Wayfarer models, which remain globally recognizable and help anchor EssilorLuxottica’s presence at the premium end of the eyewear market.

From a business-model perspective, Ray-Ban illustrates how EssilorLuxottica combines brand ownership with vertically integrated manufacturing and retail operations, including wholesale networks, company-owned stores and e-commerce platforms. By pairing Ray-Ban frames with the group’s lens technologies, EssilorLuxottica can capture value across design, production and fitting, improving unit economics and reinforcing customer loyalty.

Ray-Ban also demonstrates the company’s evolution toward omnichannel engagement, with product lines promoted through physical optical shops, branded boutiques and digital storefronts that let customers customize lenses and frame options. This approach enables EssilorLuxottica to gather data on consumer preferences, refine product development and align pricing strategies with regional demand patterns, feeding into the revenue and margin trends seen in the latest half-year results.

Closing view on EssilorLuxottica stock and current pricing

EssilorLuxottica stock currently offers investors a mix of discounted price levels versus the start of 2026, ongoing share repurchases and a fundamental profile characterized by mid-single-digit reported revenue growth, high-single-digit constant-currency expansion and double-digit adjusted operating profit increases in the first half of 2026. On the US over-the-counter market, the ESLOY American depositary receipt closed at $92.79 as of August 31, 2026 at 3:56 p.m. ET, within a daily trading range between $92.52 and $93.20 and supported by a market capitalization of $86.15 billion.

This leaves EssilorLuxottica shares trading significantly below the $158.42 level recorded at the start of 2026, a clear 41.4 percent year-to-date decline, even as the company executes a buyback program targeting up to 5 million shares and reports 7.2 percent second-quarter revenue growth and a 15 percent adjusted operating profit gain in the first half of 2026. The tension between price compression and improving fundamentals is likely to define EssilorLuxottica’s appeal for investors evaluating the stock in the months ahead.

Fact box

Company: EssilorLuxottica S.A.

ISIN: FR0000121667

Ticker: EL (Euronext Paris), ESLOY (US OTC)

Exchange: Euronext Paris; US OTC for the ESLOY depositary receipt

Price (as of August 31, 2026, 3:56 p.m. ET): $92.79 USD for ESLOY

Market cap: $86.15 billion (as of August 31, 2026)

Sector / Industry: Health care - medical supplies and consumer eyewear

Index membership: CAC 40